Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 3 of the last 3 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
13 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Lavima fertility from Aalst, company number BE0792320447, closed financial year 2025 with a result of € -168,728 after tax. For that financial year Lavima fertility recorded a gross margin of € 260,875 and equity of € -423,981. Compared with financial year 2024, the result moved from € -13,416 to € -168,728. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 17, 2026.
€ -423,981
▼ € 168,728 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -168,728
▼ 1158 % more loss than in 2024
Profit after tax over the fiscal year.
€ 87,487
▲ 33% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -428,981.
People and assets in 2025
2.8
▲ 0.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 288,425
▲ 40% vs 2024
€ 103,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 1.2 million
▲ 86% vs 2024
Loans from banks and other lenders, long and short.
€ 26,495
▼ 40% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 35,479
▲ 32% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € -230,182 | € 208,387 | € 260,875 | ▲ 25% |
| Profit after taxes | € -246,837 | € -13,416 | € -168,728 | ▼ € 155,312 |
| Equity | € -241,837 | € -255,253 | € -423,981 | ▼ € 168,728 |
| Total debts | € 340,699 | € 715,964 | € 1,287,305 | ▲ 80% |
| Cash | € 80,268 | € 65,709 | € 87,487 | ▲ 33% |
| Retained profit | € -246,837 | € -260,253 | € -428,981 | ▼ € 168,728 |
| Bank debt | € 249,849 | € 625,029 | € 1,165,219 | ▲ 86% |
| Balance sheet total | € 98,863 | € 460,712 | € 863,324 | ▲ 87% |
| Employees (FTE) | - | 2.3 | 2.8 | ▲ 0.5 |
Key figures of Lavima fertility, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Lavima fertility?
What happened at Lavima fertility in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 168,728. filed late Source: NBB ↗
- New establishment in Aalst. KBO
- Start of the company according to the CBE. KBO
- Elien Van Hecke became a director. NBB
- André Rosenthal became a director. NBB
In short
From € 246,837 loss in 2023 to € 168,728 loss in 2025.
On average € 93,200 of value added per employee in 2025.
A new publication or filing at Lavima fertility? We notify you, reason included.
Follow Lavima fertilityDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Lavima fertility are Elien Van Hecke and André Rosenthal. Elien Van Hecke is also behind Thelan Invest, Fertiga and Anakiwa.
Directors
According to the 2025 annual accounts
since 2022
André Rosenthal
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Burchtstraat 10
9300 Aalst
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 13 companies are registered at this address.
All companies at this address →Tereos Starch & Sweeteners Belgium
€ 1.6 billion revenue · 2023
ELFER
€ 138,780 gross margin · 2023
Eerstelijnszone Regio Aalst
ECOM360
€ 67,876 gross margin · 2024
MARQUISOU
+8 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0792.320.447
- VAT number
- BE 0792.320.447
- Registered office
- Burchtstraat 10, 9300 Aalst
- Names & denominations
- Lavima fertility
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 October 2022
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Activiteiten van medische beeldvorming en medische laboratoria
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Activiteiten van medische laboratoria